Xiaoguang Wang

17PUBLICATIONS
26CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 05, 2026
Preexisting TCR Clones Drive Major Pathologic Responses in Patients with HNSCC Treated with Dual Immune Checkpoint Inhibitors.

Huaibin Ge, Housaiyin Li, Aditi Kulkarni

|Nov 27, 2024
Targeting Myeloid Cells in Head and Neck Squamous Cell Carcinoma: A Kinase Inhibitor Library Screening Approach.

Mohamed Y Zaky, Jessy John, Monika Vashisht

|Sep 07, 2023
TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs.

Monika Vashisht, Huaibin Ge, Jessy John

|Apr 08, 2023
Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia.

Xiaoguang Wang, Canping Chen, Dan Vuong

|Feb 13, 2023
FAK loss reduces BRAFV600E-induced ERK phosphorylation to promote intestinal stemness and cecal tumor formation.

Chenxi Gao, Huaibin Ge, Shih-Fan Kuan

|Oct 31, 2022
Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clonotypes.

Huaibin Ge, Robert L Ferris, Jing H Wang

Pageof 3

Frequent Collaborators

2 joint publications

Zhangguo Chen

2 joint publications

Xiao-Jing Wang

2 joint publications

Robert L Ferris

2 joint publications

Huaibin Ge